Articles: 24.06 19 March 2013

Beta-blockers not associated with less morbidity/mortality in adults with CAD or CAD risk factors

Beta-blocker therapy was not associated with a reduced risk of adverse cardiovascular events in adults with a prior MI, known coronary artery disease (CAD) without prior MI, or three or more known risk factors for CAD.
Beta blockers not associated with less morbidity mortality in adults …

More details...

Beta-blockers in cardiovascular medicine: still alive and kicking

There are two fundamental facts of modern medicine: first, observational data cannot be used to reliably ascertain the effects of a treatment and, second, only randomised, blinded placebo- (or active-) controlled trials provide a robust estimate of the effects of treatment.
Beta-blockers in cardiovascular medicine still …

More details...

Current approaches to diagnosis and management of COPD

COPD is a progressive illness that requires a multidisciplinary approach to management. Our Drug review discusses its diagnosis and the available treatment options, followed by sources of further information.
Current approaches to diagnosis and management of COPD

More details...

New from NICE

Technology appraisal. Apixaban for the prevention of stroke and systemic embolism in people with nonvalvular atrial fibrillation with one or more risk factor for stroke or systemic embolism.
New from NICE

More details...

New PINCER Query Library tool to support safer prescribing

The PINCER Query Library is a new software tool to identify at-risk patients who have been prescribed drugs commonly associated with medication errors.
New PINCER Query Library tool to support safer prescribing

More details...

Perampanel: first-in-class AED for partial-onset seizures

Perampanel (Fycompa), an AMPA receptor antagonist, is licensed as adjunctive treatment of partial-onset seizures. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse events and Dr Andrew Kelso discusses its place in the treatment of epilepsy.
Perampanel first …

More details...

Recommended management of polymyalgia rheumatica

The authors describe the causes, diagnosis and recommended management of polymyalgia rheumatica, the commonest rheumatological disorder in the elderly.
Recommended management of polymyalgia rheumatica

More details...

Web design and marketing agency Leamington Spa